glp-1 agonist treatment information sources Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research GLP-1R Agonists for Weight Loss
Description
Mark Cuban Cost Plus Drug Company.
Obesity and associated metabolic disorders such as type 2 diabetes mellitus and polycystic ovary syndrome are rising globally, contributing to infertility and adverse pregnancy outcomes
It is the first GLP-1 pill approved for losing excess weight.
In conjunction with all the effects, GLP-1 RAs have been found to lower weight and aid in weight management.
